Zobrazeno 1 - 10
of 74
pro vyhledávání: '"G F, Koob"'
Autor:
E M, Fekete, Y, Zhao, A, Szücs, V, Sabino, P, Cottone, J, Rivier, W W, Vale, G F, Koob, E P, Zorrilla
Publikováno v:
British journal of pharmacology. 164(8)
Infusion of corticotropin-releasing factor (CRF)/urocortin (Ucn) family peptides suppresses feeding in mice. We examined whether rats show peripheral CRF/Ucn-induced anorexia and determined its behavioural and pharmacological bases.Male Wistar rats (
Autor:
A, Tabarin, Y, Diz-Chaves, D, Consoli, M, Monsaingeon, T L, Bale, M D, Culler, R, Datta, F, Drago, W W, Vale, G F, Koob, E P, Zorrilla, A, Contarino
Publikováno v:
The European journal of neuroscience. 26(8)
The actions of corticotropin-releasing factor (CRF) and related peptides are mediated by two receptors (CRF(1) and CRF(2)). The respective role of each subtype in the control of food intake remains poorly known. In the present study, we examined the
Publikováno v:
Dopamine in the CNS II ISBN: 9783642076596
Excellent pharmacological tools are available for manipulation of various neuropharmacological components of the dopamine system. However, a major drawback of the pharmacological approach is that almost all drug antagonists or agonists have multiple
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f95316c6c326362904c504e6d9de3158
https://doi.org/10.1007/978-3-662-06765-9_8
https://doi.org/10.1007/978-3-662-06765-9_8
Publikováno v:
European Journal of Neuroscience
European Journal of Neuroscience, Wiley, 2001, 14 (12), pp.2003-2010. ⟨10.1046/j.0953-816x.2001.01817.x⟩
European Journal of Neuroscience, 2001, 14 (12), pp.2003-2010. ⟨10.1046/j.0953-816x.2001.01817.x⟩
European Journal of Neuroscience, Wiley, 2001, 14 (12), pp.2003-2010. ⟨10.1046/j.0953-816x.2001.01817.x⟩
European Journal of Neuroscience, 2001, 14 (12), pp.2003-2010. ⟨10.1046/j.0953-816x.2001.01817.x⟩
International audience; Pregnenolone sulphate (PREGS) has generated interest as one of the most potent memory-enhancing neurosteroids to be examined in rodent learning studies, with particular importance in the ageing process. The mechanism by which
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::67b401a0c4a1622bda1b67104ba50c31
https://hal.archives-ouvertes.fr/hal-02323909
https://hal.archives-ouvertes.fr/hal-02323909
Publikováno v:
International review of neurobiology. 46
The discovery that neurosteroids could be synthesized de novo in the brain independent from the periphery and display neuronal actions led to great enthusiasm for the study of their physiological role. Pharmacological studies suggest that neurosteroi
Publikováno v:
Alcoholism, clinical and experimental research. 25(9)
The role of the delta-opioid receptor in ethanol drinking has remained unclear despite the use of traditional pharmacological and correlational approaches. The results of several studies suggest that pharmacological blockade of these receptors result
Publikováno v:
Zhongguo yao li xue bao = Acta pharmacologica Sinica. 20(12)
To study the potential role of dependence status on CB1-mediated blockade of ethanol self-administration.We examined the effects of the cannabinoid antagonist SR141716A (0, 0.03, 0.3, and 3 mg/kg) on operant ethanol (10% v/v) self-administration in m
Publikováno v:
Alcoholism, clinical and experimental research. 24(12)
Dysregulation of the stress-regulatory corticotropin-releasing factor (CRF) system in the central nucleus of the amygdala (CeA) may be a factor in genetically determined alcohol preference.To test this hypothesis, basal and restraint stress-induced C
Publikováno v:
Alcohol Research & Health
Five experts respected for their work in the development of animal models of alcohol craving offer their perspectives in a roundtable discussion format. The panel members discuss the various definitions and theories of alcohol craving and the benefit
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 293(3)
Opioid peptides long have been hypothesized to play a role in ethanol reinforcement. Neuropharmacological studies have shown that opioid receptor antagonists decrease ethanol self-administration in rodents and prevent relapse in humans. However, the